SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Isabel Fofana, Nikolaus Jilg, Raymond T. Chung, Thomas F. Baumert, Entry inhibitors and future treatment of hepatitis C, Antiviral Research, 2014, 104, 136

    CrossRef

  2. 2
    Juliane Doerrbecker, Martina Friesland, Nina Riebesehl, Corinne Ginkel, Patrick Behrendt, Richard J.P. Brown, Sandra Ciesek, Heiner Wedemeyer, Christoph Sarrazin, Lars Kaderali, Thomas Pietschmann, Eike Steinmann, Incorporation of primary patient-derived glycoproteins into authentic infectious hepatitis C virus particles, Hepatology, 2014, 60, 2
  3. 3
    Radwa Yehia Mekky, Nada Magdy El-Ekiaby, Mohammed Tarif Hamza, Noha Mousaad Elemam, Mohammed EL-sayed, Gamal Esmat, Ahmed Ihab Abdelaziz, Mir-194 is a hepatocyte gate keeper hindering HCV entry through targeting CD81 receptor, Journal of Infection, 2014,

    CrossRef

  4. 4
    Gisa Gerold, Thomas Pietschmann, Opportunities and Risks of Host-targeting Antiviral Strategies for Hepatitis C, Current Hepatitis Reports, 2013, 12, 4, 200

    CrossRef